Biotech Stocks: AI Models for Predicting Clinical Trial Success Rates
2026-03-28 · Sector Analysis
Biotech stocks experience extreme volatility around clinical trial results.
Trial Design Analysis
Endpoint selection, patient population, comparator arm, and statistical powering all influence trial success probability.
Mechanism-of-Action Scoring
Drug targets with strong genetic validation have higher success rates.
Event-Driven Trading
Binary catalysts create asymmetric risk-reward.